Abnormal heart metabolism may predict future sudden cardiac death
Hard to measure but crucial
Hard to measure but crucial
A study finds that despite the development of some new agents for highly-resistant pathogens, prescribers are reluctant to utilize these therapies.
Recent approvals of exa-cel for treatment of sickle cell disease and transfusion-dependent β-thalassemia mark the dawn of the era of gene editing in medicine. But…
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
Progress has been made in the creation of a new independent Board of Cardiovascular Medicine under the American Board of Medical Specialties, several cardiology societies…
This ecological cohort study estimates the proportion of infant and child mortality associated with armed conflict exposure from 1998 to 2019 in Colombia.
New Haven, Conn. — Yale School of Medicine and Equitable Breakthroughs in Medicine Development (EQBMED) — a multi-institute collaboration focused on clinical trial diversity —…
WASHINGTON (April 25, 2024) – Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure Society of America, the Heart Rhythm…
GPT and simulacra are pervading modern life.
Your gift now to the American Heart Association will help save lives by funding pioneering medical research, education and prevention information and more. For 100…
Amid further declines in COVID activity, the CDC reported a steady rise in JN.1 spinoffs that have two added spike mutations, part of a group…